@ARTICLE{
author={Poluzzi Elisabetta,Raschi Emanuel,Godman Brian,Koci Ariola,Moretti Ugo,Kalaba Marija,Wettermark Bjorn,Sturkenboom Miriam,De Ponti Fabrizio},
year={2018},
title={Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports Data with Drug Utilization Data Across Europe},
journal={PHARMACOEPIDEMIOLOGY AND DRUG SAFETY},
volume={27},
number={7},
pages={O10-O11},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Poluzzi Elisabetta,Raschi Emanuel,Godman Brian,Koci Ariola,Moretti Ugo,Kalaba Marija,Wettermark Bjorn,Sturkenboom Miriam,De Ponti Fabrizio},
year={2015},
title={Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe},
journal={PLOS ONE},
volume={10},
number={3},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Raschi Emanuel,Poluzzi Elisabetta,Godman Brian,Koci Ariola,Moretti Ugo,Kalaba Marija,Bennie Marion,Barbui Corrado,Wettermark Bjorn,Sturkenboom Miriam,De Ponti Fabrizio},
year={2013},
title={Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe},
journal={PLOS ONE},
volume={8},
number={11},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Raschi Emanuel,Poluzzi Elisabetta,Godman Brian,Koci Ariola,Berg Christian,Bishop Iain,Kalaba Marija,Laius Ott,Moretti Ugo,Schmitzer Manuela,Sermet Catherine,Wettermark Bjorn,Sturkenboom Miriam,De Ponti Fabrizio},
year={2012},
title={Mapping the Pro-Arrhythmic Risk of Antipsychotics: Combining Adverse Drug Reactions with Drug Utilization Data across Europe},
journal={PHARMACOEPIDEMIOLOGY AND DRUG SAFETY},
volume={21},
number={},
pages={429-429},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Poluzzi Elisabetta,Raschi Emanuel,Godman Brian,Koci Ariola,Berg Christian,Bishop Iain,Furst Jurij,Kalaba Marija,Laius Ott,Moretti Ugo,Sermet Catherine,Wettermark Bjorn,Sturkenboom Miriam,De Ponti Fabrizio},
year={2012},
title={Pro-Arrhythmic Risk of Oral Antihistamines (H1): Combining Adverse Event Reporting Data with Drug Utilization Data across Europe},
journal={PHARMACOEPIDEMIOLOGY AND DRUG SAFETY},
volume={21},
number={},
pages={293-294},
document_type={Meeting Abstract},
} 

